Glycogen synthase kinase-3β genetic polymorphisms and insomnia in depressed patients: A prospective study
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 240, 230-236
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in miceEuropean Journal of Pharmacology, 2013
- Lithium Impacts on the Amplitude and Period of the Molecular Circadian ClockworkPLOS ONE, 2012
- Functional genetic variation in the Rev-Erbαpathway and lithium response in the treatment of bipolar disorderGenes, Brain and Behavior, 2011
- Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?Neuropsychopharmacology, 2010
- A haplotype of glycogen synthase kinase 3β is associated with early onset of unipolar major depressionGenes, Brain and Behavior, 2010
- DYRK1A and Glycogen Synthase Kinase 3β, a Dual-Kinase Mechanism Directing Proteasomal Degradation of CRY2 for Circadian TimekeepingMolecular and Cellular Biology, 2010
- Nuclear Receptor Rev-Erbα: A Heme Receptor that Coordinates Circadian Rhythm and MetabolismNuclear Receptor Signaling, 2010
- Cocaine-induced hyperactivity and sensitization are dependent on GSK3Neuropharmacology, 2009
- Outcomes in major depressive disorder: The evolving concept of remission and its implications for treatmentThe World Journal of Biological Psychiatry, 2008
- Ser-557-phosphorylated mCRY2 Is Degraded upon Synergistic Phosphorylation by Glycogen Synthase Kinase-3βJournal of Biological Chemistry, 2005